GILEAD SCIENCES, INC. for GILEAD SCIENCES INC

Copyright/Patent/Trademark CPT

Technology transfer, patent rights and funding, patent reform legislation. Issues related to pharmaceuticals and intellectual property protection.

Contacted: U.S. Agency for International Development (USAID); HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); Health & Human Services, Dept of (HHS); Office of the Vice President of the United States; State, Dept of (DOS); Treasury, Dept of; Natl Economic Council (NEC); SENATE

Veterans VET

Education related to Hepatitis C

Contacted: Office of the Vice President of the United States; State, Dept of (DOS); Treasury, Dept of; U.S. Agency for International Development (USAID); SENATE; Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES; Natl Economic Council (NEC); Health & Human Services, Dept of (HHS)

Trade (domestic/foreign) TRD

International trade and protection of intellectual property

Contacted: Health & Human Services, Dept of (HHS); SENATE; State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); Office of the Vice President of the United States; Treasury, Dept of; U.S. Agency for International Development (USAID); Natl Economic Council (NEC)

Indian/Native American Affairs IND

Education related to HIV and Hepatitis C in American Indian population.

Contacted: Natl Economic Council (NEC); Health & Human Services, Dept of (HHS); Treasury, Dept of; State, Dept of (DOS); Office of the Vice President of the United States; U.S. Agency for International Development (USAID); SENATE; HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA)

Health Issues HCR

Pending healthcare legislation and potential impact on the biopharmaceutical industry. Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization; HIV/AIDS research, testing and treatment. HR.1628 American Health Care Act and S._ Better Care Reconciliation Act. HR.2212 and S.974 CREATES Act of 2017. HCV screening and linkage to care programs; coverage and reimbursement policy for HCV and HIV portfolio. HR.2430 and S.934 FDA Reauthorization Act; funding for HCV and public health activities via appropriations. Pharmaceutical policy as it relates to payments under the 340B program; implementation of section 340B drug discount program. Prison population and hepatitis C.

Contacted: Office of the Vice President of the United States; Veterans Affairs, Dept of (VA); U.S. Agency for International Development (USAID); SENATE; Treasury, Dept of; State, Dept of (DOS); Health & Human Services, Dept of (HHS); Natl Economic Council (NEC); HOUSE OF REPRESENTATIVES

Bills named: S. 974 (115th), H.R. 2430 (115th), H.R. 2212 (115th), H.R. 1628 (115th), S. 934 (115th)

Medicare/Medicaid MMM

Ryan White Care Act reauthorization; Hepatitis C policy; HIV/AIDS research, testing and treatment. HR. 1628 American Health Care Act of 2017 and S._ Better Care Reconciliation Act; HCV testing, screening and linkage to care programs. HR. 2430 and S. 934, FDA Reauthorization Act. Federal program coverage, access and reimbursement issues for Hepatitis C, HIV, and oncology products. Coverage of pharmaceuticals, cost-sharing and other access issues; issues related to coverage and reimbursement of pharmaceuticals; FDA issues and 340B.

Contacted: Treasury, Dept of; Natl Economic Council (NEC); State, Dept of (DOS); Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES; SENATE; U.S. Agency for International Development (USAID); Office of the Vice President of the United States

Bills named: H.R. 1628 (115th), S. 934 (115th), H.R. 2430 (115th)

Budget/Appropriations BUD

Funding for HCV and public health activities via appropriations. Pharmaceutical policy as it relates to payments under the 340B program.

Contacted: Natl Economic Council (NEC); Health & Human Services, Dept of (HHS); Treasury, Dept of; Veterans Affairs, Dept of (VA); SENATE; Office of the Vice President of the United States; U.S. Agency for International Development (USAID); HOUSE OF REPRESENTATIVES; State, Dept of (DOS)

Pharmacy PHA

Coverage of pharmaceuticals, cost-sharing and other access issues. HR.2212 and S.974, CREATES Act of 2017. HR. 2430 and S. 934, FDA Reauthorization Act. HR. 1628 American Health Care Act and S. _ Better Care Reconciliation Act; issues related to coverage and reimbursement of pharmaceuticals; issues related to Medicare, Medicaid, and ACA implementation; FDA issues and 340B.

Contacted: Treasury, Dept of; Health & Human Services, Dept of (HHS); State, Dept of (DOS); U.S. Agency for International Development (USAID); HOUSE OF REPRESENTATIVES; SENATE; Natl Economic Council (NEC); Veterans Affairs, Dept of (VA); Office of the Vice President of the United States

Bills named: S. 934 (115th), H.R. 1628 (115th), H.R. 2430 (115th), H.R. 2212 (115th), S. 974 (115th)

Foreign Relations FOR

Issues related to pharmaceuticals and international finance for health services. Intellectual property protection.

Contacted: HOUSE OF REPRESENTATIVES; SENATE; U.S. Agency for International Development (USAID); Office of the Vice President of the United States; Treasury, Dept of; Health & Human Services, Dept of (HHS); State, Dept of (DOS); Veterans Affairs, Dept of (VA); Natl Economic Council (NEC)

Taxation/Internal Revenue Code TAX

Issues related to international and corporate tax reform

Contacted: Office of the Vice President of the United States; HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA); SENATE; Treasury, Dept of; U.S. Agency for International Development (USAID); Natl Economic Council (NEC)